Home › Companies › ROIVANT SCIENCES LTD. › 2024-2025

ROIVANT SCIENCES LTD. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ROIVANT SCIENCES LTD.’s Form 8-K, filed 2024-09-16 (Item 5.07 on EDGAR). Page generated 02 October 2026.

13Reported items
262Asset managers
2,213Fund votes
2024-09-10Meeting date

Proxy season: 2024-2025 2025-2026

Explore ROIVANT SCIENCES LTD. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ROIVANT SCIENCES LTD.

These tallies are ROIVANT SCIENCES LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-09-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ROIVANT SCIENCES LTD. — official shareholder meeting results, meeting held 2024-09-10
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Ilan Oren	409,647,664	--	--	195,587,109	74,881,529	Majority: yes
Elect Director: James C. Momtazee	457,800,746	--	--	147,434,027	74,881,529	Majority: yes
Elect Director: Dr. Mayukh Sukhatme	602,544,381	--	--	2,690,392	74,881,529	Majority: yes
Proposal 4	679,096,310	759,669	260,323	--	--	Majority: yes
Proposal 5	540,184,951	64,461,892	587,930	--	74,881,529	Majority: yes

Source: ROIVANT SCIENCES LTD., Form 8-K, filed with the SEC on 2024-09-16 — read the filing on EDGAR.

How asset managers voted at the ROIVANT SCIENCES LTD. 2024-2025 meeting

Each item below shows how the 262 asset managers that disclosed a ROIVANT SCIENCES LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ROIVANT SCIENCES LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To cast a non-binding, advisory vote to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

79% fund support · no official result

FOR 79%AGAINST 21%

The 243 asset managers below cast 79% of the shares they voted on this item FOR (325,922,630 for, 84,952,725 against).

FOR: 325,922,630 (79.2%)AGAINST: 84,952,725 (20.6%)ABSTAIN: 810,643 (0.2%)NOT VOTED: 240 (0.0%)

Largest asset managers voting on “To cast a non-binding, advisory vote to approve the compensation of our named executive officers.” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Against	Abstain	Vote
Fidelity	5,507,393	72,296,364	0	Against
VIKING GLOBAL INVESTORS LP	66,924,269	0	0	For
QVT Financial LP	66,719,779	0	0	For
Morgan Stanley	32,637,682	0	0	For
BlackRock	31,507,227	33,867	0	For
State Street	15,285,594	814	0	For
Vanguard	10,345,708	0	0	For
Invesco	9,505,861	0	0	For
Woodline Partners LP	7,037,324	0	0	For
Rubric Capital Management LP	6,782,179	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	5,942,231	0	0	For
Two Seas Capital LP	5,710,472	0	0	For
Capital Group	4,832,642	0	0	For
Charles Schwab	4,248,991	0	0	For
Nuveen	3,211,988	0	0	For
TIAA	3,189,883	0	0	For
First Trust	3,103,240	0	2,000	For
Goldman Sachs	2,910,407	855	0	For
Loomis Sayles	130,250	2,726,361	0	Against
Pertento Partners LLP	2,652,562	0	0	For
Northern Trust	2,415,926	362	0	For
Aberdeen	2,253,974	0	0	For
MELLON INVESTMENTS Corp	1,954,419	0	0	For
TOMS Capital Investment Management LP	1,920,651	0	0	For
Clearbridge Investments, LLC	1,860,536	0	0	For

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

2. To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every:

SECTION 14A SAY-ON-PAY VOTES

Combines 10 wordings of this item as funds reported it.

99.6% fund support · no official result

ONE YEAR 66%1 YEAR 31%

The 240 asset managers below cast 99.6% of the shares they voted on this item FOR (3,223,303 for, 9,900 against).

FOR: 3,223,303 (0.8%)AGAINST: 9,900 (0.0%)ABSTAIN: 809,078 (0.2%)ONE YEAR: 268,698,764 (65.6%)1 YEAR: 129,009,311 (31.5%)1: 5,815,472 (1.4%)3 YEARS: 2,327,481 (0.6%)1-YEAR: 911 (0.0%)NOT VOTED: 240 (0.0%)

Largest asset managers voting on “To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the com” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Vote
Fidelity	0	One Year
VIKING GLOBAL INVESTORS LP	0	One Year
QVT Financial LP	0	1 Year
Morgan Stanley	0	One Year
BlackRock	2,710,836	1 Year
State Street	0	One Year
Vanguard	0	One Year
Invesco	0	One Year
Woodline Partners LP	0	One Year
Rubric Capital Management LP	0	1 Year
GEODE CAPITAL MANAGEMENT, LLC	0	One Year
Two Seas Capital LP	0	1
Capital Group	0	1 Year
Charles Schwab	0	1 Year
Nuveen	0	One Year
TIAA	0	One Year
First Trust	0	One Year
Goldman Sachs	0	One Year
Loomis Sayles	0	One Year
Pertento Partners LLP	0	1 Year
Northern Trust	0	1 Year
Aberdeen	0	One Year
MELLON INVESTMENTS Corp	0	One Year
TOMS Capital Investment Management LP	0	3 Years
Clearbridge Investments, LLC	0	One Year

Showing the 25 largest of 240 asset managers. See all 240 in the interactive database.

3. To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan Oren

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD 32%

FOR: 409,647,664WITHHELD: 195,587,109

ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Ilan Oren”): 409,647,664 for, 195,587,109 withheld, per its Form 8-K filed 2024-09-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 739,053,106 outstanding shares: 55% for, 26% withheld (82% of the company cast a for/withheld vote).

The 72 asset managers below cast 100% of the shares they voted on this item FOR (33,541,414 for, 0 against).

FOR 33%ABSTAIN 67%

FOR: 33,541,414 (32.9%)ABSTAIN: 68,285,264 (67.1%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Ilan Or” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	5,331,113	26,091,057	Abstain
BlackRock	0	18,354,542	Abstain
Vanguard	9,537,666	0	For
Morgan Stanley	8,318,539	23,833	For
State Street	0	4,894,717	Abstain
Invesco	0	4,623,241	Abstain
TIAA	3,189,883	0	For
First Trust	0	3,082,289	Abstain
Goldman Sachs	0	2,622,027	Abstain
Charles Schwab	2,122,291	0	For
Transamerica	1,842,461	0	For
IMPAX FUNDS SERIES TRUST I	0	1,600,000	Abstain
Brighthouse	765,910	380,933	For
Aberdeen	0	1,126,987	Abstain
Equitable	276,289	631,346	Abstain
Jackson National	686,042	0	For
Direxion Shares ETF Trust	0	582,211	Abstain
FRANKLIN STRATEGIC SERIES	0	346,000	Abstain
Delaware/Macquarie	0	338,181	Abstain
Columbia Threadneedle	0	332,855	Abstain
Mercer Funds	0	326,459	Abstain
MoA Funds Corp	0	318,416	Abstain
Northern Trust	261,743	0	For
Bridge Builder Trust	0	223,278	Abstain
Nationwide	0	223,097	Abstain

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

4. To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: James C. Momtazee

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD 24%

FOR: 457,800,746WITHHELD: 147,434,027

ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: James C. Momtazee”): 457,800,746 for, 147,434,027 withheld, per its Form 8-K filed 2024-09-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 739,053,106 outstanding shares: 62% for, 20% withheld (82% of the company cast a for/withheld vote).

The 72 asset managers below cast 100% of the shares they voted on this item FOR (64,309,606 for, 0 against).

FOR 63%ABSTAIN 37%

FOR: 64,309,606 (63.2%)ABSTAIN: 37,517,072 (36.8%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: James C” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	5,507,393	25,914,777	Abstain
BlackRock	18,354,542	0	For
Vanguard	9,537,666	0	For
Morgan Stanley	8,342,372	0	For
State Street	4,894,717	0	For
Invesco	4,623,241	0	For
TIAA	3,189,883	0	For
First Trust	0	3,082,289	Abstain
Goldman Sachs	0	2,622,027	Abstain
Charles Schwab	2,122,291	0	For
Transamerica	1,842,461	0	For
IMPAX FUNDS SERIES TRUST I	1,600,000	0	For
Brighthouse	765,910	380,933	For
Aberdeen	0	1,126,987	Abstain
Equitable	433,054	474,581	Abstain
Jackson National	686,042	0	For
Direxion Shares ETF Trust	0	582,211	Abstain
FRANKLIN STRATEGIC SERIES	0	346,000	Abstain
Delaware/Macquarie	0	338,181	Abstain
Columbia Threadneedle	332,855	0	For
Mercer Funds	0	326,459	Abstain
MoA Funds Corp	0	318,416	Abstain
Northern Trust	261,743	0	For
Bridge Builder Trust	25,576	197,702	Abstain
Nationwide	0	223,097	Abstain

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

5. To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Mayukh Sukhatme

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 602,544,381WITHHELD: 2,690,392

ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Dr. Mayukh Sukhatme”): 602,544,381 for, 2,690,392 withheld, per its Form 8-K filed 2024-09-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 739,053,106 outstanding shares: 82% for, 0.4% withheld (82% of the company cast a for/withheld vote).

The 72 asset managers below cast 100% of the shares they voted on this item FOR (100,868,553 for, 0 against).

FOR 99.0%

FOR: 100,868,553 (99.1%)ABSTAIN: 958,125 (0.9%)

Largest asset managers voting on “To elect the Board of Directors' three nominees for Class III Director to serve for a three-year term: Mayukh ” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	31,422,170	0	For
BlackRock	18,354,542	0	For
Vanguard	9,537,666	0	For
Morgan Stanley	8,342,372	0	For
State Street	4,894,717	0	For
Invesco	4,623,241	0	For
TIAA	3,189,883	0	For
First Trust	3,082,289	0	For
Goldman Sachs	2,622,027	0	For
Charles Schwab	2,122,291	0	For
Transamerica	1,842,461	0	For
IMPAX FUNDS SERIES TRUST I	1,600,000	0	For
Brighthouse	1,074,817	72,026	For
Aberdeen	1,126,987	0	For
Equitable	907,635	0	For
Jackson National	0	686,042	Abstain
Direxion Shares ETF Trust	582,211	0	For
FRANKLIN STRATEGIC SERIES	346,000	0	For
Delaware/Macquarie	338,181	0	For
Columbia Threadneedle	332,855	0	For
Mercer Funds	326,459	0	For
MoA Funds Corp	318,416	0	For
Northern Trust	261,743	0	For
Bridge Builder Trust	223,278	0	For
Nationwide	223,097	0	For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

6. To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2025, and to authorize the Board of Direct

AUDIT-RELATED

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 70 asset managers below cast 100% of the shares they voted on this item FOR (101,513,040 for, 0 against).

FOR: 101,513,040 (99.9%)ABSTAIN: 74,815 (0.1%)

Largest asset managers voting on “To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's ind” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Abstain	Vote
Fidelity	31,422,170	0	For
BlackRock	18,354,542	0	For
Vanguard	9,537,666	0	For
Morgan Stanley	8,342,372	0	For
State Street	4,894,717	0	For
Invesco	4,623,241	0	For
TIAA	3,189,883	0	For
First Trust	3,082,289	0	For
Goldman Sachs	2,622,027	0	For
Charles Schwab	2,122,291	0	For
Transamerica	1,842,461	0	For
IMPAX FUNDS SERIES TRUST I	1,600,000	0	For
Brighthouse	1,074,817	72,026	For
Aberdeen	1,126,987	0	For
Equitable	907,635	0	For
Jackson National	686,042	0	For
Direxion Shares ETF Trust	582,211	0	For
FRANKLIN STRATEGIC SERIES	346,000	0	For
Delaware/Macquarie	338,181	0	For
Columbia Threadneedle	332,855	0	For
Mercer Funds	326,459	0	For
MoA Funds Corp	318,416	0	For
Northern Trust	261,743	0	For
Bridge Builder Trust	223,278	0	For
Nationwide	223,097	0	For

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

7. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

11%1 YEAR 53.1%2 YEAR 23%12%

The 7 asset managers below cast 100% of the shares they voted on this item FOR (300,782 for, 0 against).

FOR: 300,782 (10.5%)1 YEAR: 1,514,902 (53.1%)2 YEAR: 649,700 (22.8%)3 YEAR: 341,860 (12.0%)1: 45,840 (1.6%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Vote
DME Capital Management, LP	0	1 Year
Pier Capital, LLC	253,405	For
Dunham Funds	47,377	For
RBB FUND, INC.	0	1
MQS Management LLC	0	1 Year
COURIER CAPITAL LLC	0	1
Tyro Capital Management LLC	0	--

8. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 93%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (68,482,995 for, 0 against).

FOR: 68,482,995 (93.4%)1-YEAR: 3,669,200 (5.0%)ONE YEAR: 1,184,883 (1.6%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Vote
SB INVESTMENT ADVISERS (UK) LTD	68,482,995	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	0	1-Year
JPMorgan	0	One Year
EFG Asset Management (North America) Corp.	0	One Year
Empower	0	One Year
Desjardins Global Asset Management Inc.	0	One Year

9. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

99% fund support · no official result

FOR 99%

The 6 asset managers below cast 99% of the shares they voted on this item FOR (72,475,195 for, 861,883 against).

FOR: 72,475,195 (98.8%)AGAINST: 861,883 (1.2%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Against	Vote
SB INVESTMENT ADVISERS (UK) LTD	68,482,995	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	3,669,200	0	For
JPMorgan	0	708,992	Against
EFG Asset Management (North America) Corp.	323,000	0	For
Empower	0	150,748	Against
Desjardins Global Asset Management Inc.	0	2,143	Against

10. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (2,506,962 for, 0 against).

FOR: 2,506,962 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Vote
DME Capital Management, LP	2,505,546	For
MQS Management LLC	916	For
COURIER CAPITAL LLC	500	For
Tyro Capital Management LLC	0	--

11. 14A Executive Compensation To cast a non-binding, advisory vote to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (346,122 for, 0 against).

FOR: 346,122 (100.0%)

Largest asset managers voting on “14A Executive Compensation To cast a non-binding, advisory vote to approve the compensation of our named execu” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Vote
Pier Capital, LLC	253,405	For
Dunham Funds	47,377	For
RBB FUND, INC.	45,340	For

12. Ratify Appointment of Independent Auditors To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2025, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31,

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (92,717 for, 0 against).

FOR: 92,717 (100.0%)

Largest asset managers voting on “Ratify Appointment of Independent Auditors To ratify the selection by the Audit Committee of the Board of Dire” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Dunham Funds	47,377	0	0	0	For
RBB FUND, INC.	45,340	0	0	0	For

13. Say on pay

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (276,530 for, 0 against).

FOR: 276,530 (100.0%)

Largest asset managers voting on “Say on pay” at ROIVANT SCIENCES LTD., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Pine Ridge Advisers LLC	276,530	0	0	0	For
Ikarian Capital, LLC	0	0	0	0	--

Largest ROIVANT SCIENCES LTD. shareholders voting in 2024-2025

Ranked by the number of ROIVANT SCIENCES LTD. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 739,053,106 shares outstanding at the time of that meeting.

Top ROIVANT SCIENCES LTD. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Fidelity	10.53%
2	VIKING GLOBAL INVESTORS LP	9.06%
3	QVT Financial LP	9.03%
4	Morgan Stanley	4.42%
5	BlackRock	4.27%
6	State Street	2.07%
7	Vanguard	1.40%
8	Invesco	1.29%
9	Woodline Partners LP	0.95%
10	Rubric Capital Management LP	0.92%

Reported ROIVANT SCIENCES LTD. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ROIVANT SCIENCES LTD. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Roivant Sciences Ltd.	15.33%	13D
Dexxon Holdings	13.92%	DEF14A
Vivek Ramaswamy	10.85%	DEF14A
SVF Investments	8.40%	DEF14A
FMR (Fidelity)	6.99%	13F
FMR LLC	6.65%	DEF14A
Viking Global Entities	6.23%	DEF14A
BlackRock	5.64%	13F
Vanguard Group	5.52%	13F
Morgan Stanley	4.86%	13F

Percentages above are of 739,053,106 shares outstanding, as reported by ROIVANT SCIENCES LTD. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROIVANT SCIENCES LTD.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ROIVANT SCIENCES LTD.'s shareholder meeting held 2024-09-10, in the 2024-2025 proxy season, 262 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,213 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ROIVANT SCIENCES LTD.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To cast a non-binding, advisory vote to approve the compensation of our named executive… — the reporting funds cast 79% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

ROIVANT SCIENCES LTD. proxy season coverage: 2024-2025 (this page) · 2025-2026.